Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sarcoma, Ewing 1 Pain 1 Osteosarcoma 1 Osteonecrosis 1 Nasopharyngeal Carcinoma 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Leukemia 1 Hodgkin Disease 1 Exostoses, Multiple Hereditary 1 Deglutition Disorders 1 Colonic Neoplasms 1 Chondrosarcoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Iodine-131 21 lenvatinib 17 Magnetic Resonance Spectroscopy 17 trametinib 13 Sorafenib 13 Thyrotropin Alfa 12 pembrolizumab 11 dabrafenib 11 Thyroidectomy 10 Surgical Procedures, Operative 10 Thyroxine 9 Paclitaxel 9 vandetanib 8 selpercatinib 8 Sunitinib 7 Nivolumab 7 Fluorodeoxyglucose F18 7 cabozantinib 6 anlotinib 6 Everolimus 6 Biopsy 6 pazopanib 5 Vemurafenib 5 Triiodothyronine 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Iodine-124 5 Cyclophosphamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Range of Motion, Articular × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡